absolute biotech

Newly launched Absolute Biotech integrates multiple brands to offer antibody reagents, services to researchers worldwide

Absolute Biotech was launched on October 4, 2022 as a unified company joining together leading antibody-centric brands from around the world. Absolute Biotech specializes in antibody reagents and services, adding value to existing antibodies, reagents and kits through annotation, validation, sequencing, engineering and recombinant manufacturing. The combined company will leverage each brand’s unique antibody expertise […]

Schermafbeelding 2022 10 27 om 15.52.08

PROCALCITONIN FS

shutterstock 2105845253

New developments in LC-MS/MS

In their aim to support researchers and clinicians, companies such as Thermo Fisher Scientific are also at the forefront of their own R&D. CLI caught up with Dr Edward Goucher, Senior Manager of Business Development, to discuss their new developments.

shutterstock 689826262

Analysis of illicit drugs in purchased and seized electronic cigarette liquids from the United Kingdom 2014-2021

Frinculescu A, Coombes G, Shine T et al. Drug Test Anal 2022;doi:10.1002/dta.3277 Increasing popularity and known shortfalls in the regulation of electronic cigarettes (ECs) emphasizes the urgent need for closer content monitoring and for comprehensible information on their possible health effects.

Fig1

Diagnostic value of combined detection of tumour markers for 143 cases of primary hepatic carcinoma

by Xijun Min, Dr Yan Li, Liuyan Chen, Chengwei Yao, Dr Xi Qin As a traditional tumour marker for the diagnosis of early primary hepatic carcinoma (PHC), alpha fetoprotein (AFP) has a low positive rate. Serum glypican 3 (GPC3) is a novel biomarker, and the combined examination of GPC3 and AFP will provide a new […]

Schermafbeelding 2022 10 27 om 14.13.55

The Intelligent Analyzer

ALCAM Fig1v2

Urinary ALCAM as a biomarker for lupus nephritis

by Dr Cherie Ng and Dr Chaim Putterman Lupus nephritis is an immune-mediated glomerulonephritis that causes significant morbidity and mortality in patients with systemic lupus erythematous, a multisystem autoimmune disease. Non-invasive biomarkers are necessary to track disease and treatment response. Urinary ALCAM is a potential biomarker that samples the kidney and is relevant to the […]

Schermafbeelding 2022 10 27 om 13.58.02

For your emergency markers

shutterstock 1663310779

Secretoneurin: a potential complementary cardiovascular biomarker

Secretoneurin is a novel prognostic biomarker that may predict mortality in heart failure and the occurrence of ventricular arrhythmias. CLI caught up with Professor Torbjørn Omland (University of Oslo, Oslo, Norway) to find out more about it.